New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
NovoCure Limited
NVCR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

3B

Medical - Instruments & Supplies

Next Earning date - 27 Feb 2025

3B

Medical - Instruments & Supplies

Next Earning date - 27 Feb 2025

24.18USD

Shape0.51 ( 2.15%)
sun-fogPre-market 24.27$arrow-right-up0.09 (0.37%)
Market Closed (as of Feb 05, 21:00 EDT)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

-50%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

29%

Quote Panel

Shape
Updated February 6, 2025
1W -1.39 % 1M -16.65 % 3M 37.00 % 1Y 61.63 %

Key Metrics

Shape
  • Market Cap

    2.62B


  • Shares Outstanding

    108.20M


  • Share in Float

    96.95M


  • Dividende

    0


  • Earning Date

    27 Feb 2025


  • Price Target

    24.18


  • Average Volume

    1.23M


  • Beta

    0.705


  • Range

    11.7-34.13


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.novocure.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

NVCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$613M

Shape295%

2025-Revenue

$1.69

Shape-505%

2025-EPS

$49M

Shape-66%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

30.00(24.07%)

Number of analyst

1

Last analyst upgrade/downgrade

H.C. Wainwright

upgrade

Previous: Neutral

2024-10-16

Now: Buy

Piper Sandler

upgrade

Previous: Neutral

2023-08-08

Now: Overweight

Wedbush

upgrade

Previous: Not converted

2023-06-07

Now: Neutral

Wells Fargo

upgrade

Previous: Equal-Weight

2023-05-16

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.36
vs -0.25

Q1.23

arrow
arrow

N/A

-0.50
vs -0.04

Q2.23

arrow
arrow

N/A

-0.54
vs -0.23

Q3.23

arrow
arrow

N/A

-0.46
vs -0.25

Q4.23

arrow
arrow

N/A

-0.45
vs -0.36

Q1.24

arrow
arrow

N/A

-0.36
vs -0.50

Q2.24

arrow
arrow

N/A

-0.31
vs -0.54

Q3.24

arrow
arrow

N/A

-0.28
vs -0.46

Q4.24

arrow
arrow

N/A

-0.34
vs -0.45

Q1.25

arrow
arrow

N/A

-0.41
vs -0.36

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-4%

128.4M  vs 133.2M

Q1.23

arrow
arrow

-11%

122.2M  vs 137.5M

Q2.23

arrow
arrow

-11%

126.1M  vs 140.9M

Q3.23

arrow
arrow

-3%

127.3M  vs 131M

Q4.23

arrow
arrow

+4%

133.8M  vs 128.4M

Q1.24

arrow
arrow

+13%

138.5M  vs 122.2M

Q2.24

arrow
arrow

+19%

150.4M  vs 126.1M

Q3.24

arrow
arrow

+22%

155.1M  vs 127.3M

Q4.24

arrow
arrow

+21%

161.3M  vs 133.8M

Q1.25

arrow
arrow

+9%

150.7M  vs 138.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-8%

-0.08
vs -0.06

Q1.23

arrow
arrow

-12%

-0.12
vs -0.08

Q2.23

arrow
arrow

-14%

-0.14
vs -0.12

Q3.23

arrow
arrow

-13%

-0.13
vs -0.14

Q4.23

arrow
arrow

-13%

-0.13
vs -0.13

Q1.24

arrow
arrow

-11%

-0.11
vs -0.13

Q2.24

arrow
arrow

-9%

-0.09
vs -0.11

Q3.24

arrow
arrow

-8%

-0.08
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

339

339
vs 319

6%

Q1.23

arrow
arrow

320

320
vs 339

-6%

Q2.23

arrow
arrow

291

291
vs 320

-9%

Q3.23

arrow
arrow

255

255
vs 291

-12%

Q4.23

arrow
arrow

241

241
vs 255

-5%

Q1.24

arrow
arrow

258

258
vs 241

7%

Q2.24

arrow
arrow

249

249
vs 258

-3%

Q3.24

arrow
arrow

236

236
vs 249

-5%

Earnings Growth

Latest News